Novoprotein reported a net loss of 54.8068 million yuan for the fiscal year 2024
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Novoprotein released its 2024 annual performance preliminary report, stating that the total operating revenue for 2024 was 127 million yuan, a year-on-year decrease of 16.81%; the net loss attributable to the parent company's owners was 54.8068 million yuan; the net loss attributable to the parent company's owners after deducting non-recurring gains and losses was 72.2141 million yuan; the basic loss per share was 0.78 yuan
According to the Zhitong Finance APP, Novoprotein (688137.SH) released its annual performance preliminary report for 2024. The total operating revenue for 2024 is 127 million yuan, a year-on-year decrease of 16.81%; the net loss attributable to the parent company's owners is 54.8068 million yuan; the net loss attributable to the parent company's owners after deducting non-recurring gains and losses is 72.2141 million yuan; the basic loss per share is 0.78 yuan